FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes

00:00 - 16 Dec 2025

The US Food and Drug Administration (FDA) recently approved elinzanetant, marketed as Lynkuet, for moderate to severe hot flashes due to menopause, the third FDA-approved nonhormonal treatment option for vasomotor symptoms, which include hot flashes and night sweats.